Axio Biosolutions
Ahmedabad-based medtech company that makes chitosan-based hemostatic and advanced wound-care products (Axiostat, MaxioCel) for trauma, military, surgical and chronic-wound-care markets; a wholly owned subsidiary of Boston-based Advamedica Inc.
Axio Biosolutions: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 27 Jul 2021 | Series B2 | $6 Mn | TrueScale Capital Accel India Omidyar Network India UC-RNT Fund | source |
| 9 Jan 2020 | Series B-1 | $5.2 Mn | Omidyar Network India Accel India Chiratae Ventures UC-RNT Fund | source |
| 26 Jan 2018 | Series B | $7.4 Mn | RNT Capital Accel India Chiratae Ventures | source |
| 1 Jan 2016 | Series A | $2.1 Mn | Accel India Chiratae Ventures | source |
| 1 Jan 2010 | Seed | Undisclosed | GVFL | source |
Recent Signals
News on Axio Biosolutions
No coverage of Axio Biosolutions linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on Axio Biosolutions
Who founded Axio Biosolutions?
Axio Biosolutions was founded by Leo Mavely in 2008.
How much funding has Axio Biosolutions raised?
Axio Biosolutions has raised $20.7 Mn across 5 tracked funding round(s), most recently on 2021-07-27. Figures are compiled from cited public sources.
Who are the investors in Axio Biosolutions?
Investors in Axio Biosolutions include TrueScale Capital, Accel India, Omidyar Network India, UC-RNT Fund, Chiratae Ventures, RNT Capital.
What does Axio Biosolutions do?
Ahmedabad-based medtech company that makes chitosan-based hemostatic and advanced wound-care products (Axiostat, MaxioCel) for trauma, military, surgical and chronic-wound-care markets; a wholly owned subsidiary of Boston-based Advamedica Inc.
Where is Axio Biosolutions headquartered?
Axio Biosolutions is headquartered in Ahmedabad, Gujarat, India.
What is Axio Biosolutions's business model?
Axio Biosolutions's core value proposition centers on Fast, natural bleeding control, Effective across trauma, military and vascular use cases, Accelerated chronic-wound healing.
How does Axio Biosolutions make money?
Axio Biosolutions's cited revenue streams include Product sales (Axiostat, MaxioCel).